NCT03826966

Brief Summary

This research is being done to find out whether an app based cognitive behavior therapy called reSET improves the adherence to and outcome of buprenorphine treatment for opioid use disorder (OUD) in the setting of a Hub and Spoke implementation system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2019

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 1, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 4, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

July 8, 2020

Status Verified

July 1, 2020

Enrollment Period

11 months

First QC Date

January 11, 2019

Last Update Submit

July 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Retention in treatment on MAT for 6 months after enrolling in the study

    ReSET is a mobile app designed to provide extended cognitive behavioral therapy for patients initiating medication assisted treatment (MAT) for opioid use disorder (OUD). This pilot trial is evaluating the acceptability and feasibility of the app, reSET. The first outcome being measure is treatment retention. We want to examine if participants enrolled in the study will maintain on MAT for 6 months after enrollment. This will be evaluated based on the number of appointments attended by the research participants. Data mining through our systems electronic medical record (EMR) will be conducted in order to count the number of attended appointments for study participants to gauge their treatment retention.

    6 months

Secondary Outcomes (12)

  • Opioid and other substance abuse as assessed through biological specimen

    6 months

  • Opioid and other substance abuse as assessed through participant self-report

    6 months

  • Cravings to use drugs as assessed by the reSET app

    6 months

  • Overall mental health symptoms related to depression and anxiety as assessed by the K-10

    6 months

  • Mental health symptoms specific to depression as assessed by the PHQ-9

    6 months

  • +7 more secondary outcomes

Interventions

reSETDEVICE

reSET is a mobile app created by Pear Therapeutics, Inc., which has previously been approved by the FDA.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Starting outpatient treatment for OUD within the PACMAT Hub and Spoke system (either the Hub or one of the Spokes)
  • Planning maintenance treatment with buprenorphine
  • Willing to participate in the study
  • Can read, write and comprehend English

You may not qualify if:

  • Planning an outpatient detoxification, or treatment other than buprenorphine maintenance (e.g. methadone maintenance, Vivitrol, or counseling with no medication)
  • Judged by the evaluating physician or allied clinician to need a higher level of care (e.g. residential or inpatient treatment)
  • Unwilling to participate in the study
  • Under the age of 18
  • Unable to read, write and comprehend English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennsylvania Psychiatric Institute, Opioid Treatment Program

Harrisburg, Pennsylvania, 17110, United States

Location

MeSH Terms

Conditions

Behavior, AddictiveOpioid-Related Disorders

Condition Hierarchy (Ancestors)

Compulsive BehaviorImpulsive BehaviorBehaviorNarcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
N/A at this time. This trial is a pilot study seeking an N of 15 participants. All participants will be assigned the "treatment," which is accessing an mobile app, re-SET, for cognitive behavioral therapy extension that is to be used with MAT (Buprenorphine only at this time).
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 11, 2019

First Posted

February 1, 2019

Study Start

March 4, 2019

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

July 8, 2020

Record last verified: 2020-07

Locations